Literature DB >> 12842085

Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis.

Yoshiharu Miyamoto1, Anirban Maitra, Bidyut Ghosh, Ulrich Zechner, Pedram Argani, Christine A Iacobuzio-Donahue, Virote Sriuranpong, Tatsuya Iso, Ingrid M Meszoely, Michael S Wolfe, Ralph H Hruban, Douglas W Ball, Roland M Schmid, Steven D Leach.   

Abstract

Notch signaling regulates cell fate decisions in a wide variety of adult and embryonic tissues. Here we show that Notch pathway components and Notch target genes are upregulated in invasive pancreatic cancer, as well as in pancreatic cancer precursors from both mouse and human. In mouse pancreas, ectopic Notch activation results in accumulation of nestin-positive precursor cells and expansion of metaplastic ductal epithelium, previously identified as a precursor lesion for pancreatic cancer. Notch is also activated as a direct consequence of EGF receptor activation in exocrine pancreas and is required for TGF alpha-induced changes in epithelial differentiation. These findings suggest that Notch mediates the tumor-initiating effects of TG alpha by expanding a population of undifferentiated precursor cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12842085     DOI: 10.1016/s1535-6108(03)00140-5

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  261 in total

1.  Aberrant signaling pathways in pancreatic cancer: a two compartment view.

Authors:  Angela L McCleary-Wheeler; Robert McWilliams; Martin E Fernandez-Zapico
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

2.  Ongoing Notch signaling maintains phenotypic fidelity in the adult exocrine pancreas.

Authors:  Daniel Kopinke; Marisa Brailsford; Fong Cheng Pan; Mark A Magnuson; Christopher V E Wright; L Charles Murtaugh
Journal:  Dev Biol       Date:  2011-11-29       Impact factor: 3.582

Review 3.  Non-canonical activation of Notch signaling/target genes in vertebrates.

Authors:  Rajendran Sanalkumar; Sivadasan Bindu Dhanesh; Jackson James
Journal:  Cell Mol Life Sci       Date:  2010-05-11       Impact factor: 9.261

Review 4.  Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.

Authors:  Jiao Zhang; Yan-Hua Chen; Qun Lu
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

Review 5.  Molecular mechanism of pancreatic cancer--understanding proliferation, invasion, and metastasis.

Authors:  André L Mihaljevic; Christoph W Michalski; Helmut Friess; Jörg Kleeff
Journal:  Langenbecks Arch Surg       Date:  2010-03-18       Impact factor: 3.445

Review 6.  Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.

Authors:  Andrew D Rhim; Ben Z Stanger
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

7.  Lineage tracing reveals the dynamic contribution of Hes1+ cells to the developing and adult pancreas.

Authors:  Daniel Kopinke; Marisa Brailsford; Jill E Shea; Rebecca Leavitt; Courtney L Scaife; L Charles Murtaugh
Journal:  Development       Date:  2011-02       Impact factor: 6.868

Review 8.  Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence.

Authors:  Veronique Giroux; Anil K Rustgi
Journal:  Nat Rev Cancer       Date:  2017-09-01       Impact factor: 60.716

Review 9.  Pancreatic cancer stem cells: fact or fiction?

Authors:  Vikash J Bhagwandin; Jerry W Shay
Journal:  Biochim Biophys Acta       Date:  2009-02-21

10.  Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.

Authors:  Vindhya Palagani; Mona El Khatib; Uta Kossatz; Przemyslaw Bozko; Martin R Müller; Michael P Manns; Till Krech; Nisar P Malek; Ruben R Plentz
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.